It’s easy to forget that there’s a subnet on Bittensor whose entire purpose is to develop real drugs. NOVA is that subnet and in their latest update, the team walked through what’s happening under the […]
Full article credit: Subnet Summer Rare diseases remain one of healthcare’s most persistent blind spots, not because the science is missing, but because the data is fragmented. For millions of patients worldwide, diagnosis can take […]
Speaking on Hashrate with Mark Jeffrey, Metanova CEO Micaela described the project as a crypto biotech company building on the Bittensor network, with a focus on AI-driven drug discovery. More on Metanova (SN68): Metanova launched […]
This article was fully written by bhaws. The point of this article is to highlight an ecosystem I think is worth studying critically and in depth. DYOR “If you can properly define a problem, if […]
In any competitive system, the structure of incentives determines the quality of outcomes. When rewards are distributed continuously regardless of meaningful progress, systems tend to plateau, with participants optimizing for retention rather than improvement. NOVA […]
One year ago, on March 1, 2025, Metanova Labs launched NOVA, their flagship project on Bittensor’s Subnet 68 (SN68). This marked the beginning of a revolutionary approach to AI-driven drug discovery, blending biotechnology with decentralized […]
© Copyright 2026 The TAO Daily